Top

Category: Research and Development


Clinical Trials, Research and Development

Pharmacy chain Walgreens plans to disrupt clinical trial sector

June 17, 2022

Via: Pharmaphorum

The company says it plans to use a “flexible” model, drawing on both decentralised trial (DCT) and conventional site-based models via its Health Corner and Village Medical outlets at various Walgreens locations across the US. The move follows in the […]


Clinical Trials, Research and Development

Another amyloid miss in Alzheimer’s as Roche’s crenezumab fails trial

June 16, 2022

Via: Pharmaphorum

The result isn’t a big surprise – Roche terminated two phase 3 trials of crenezumab in people with prodromal to mild sporadic Alzheimer’s in early 2019 after interim analyses found it would be futile to continue – but is another […]


Industry, Manufacturing, Research and Development, Vaccines

EU governments pressure manufacturers to renegotiate contracts for COVID-19 vaccines

June 15, 2022

Via: PMLiVE

When vaccines became available earlier in the COVID-19 pandemic, countries vied for supply contracts. However, as the need for vaccines begins to slow in Europe, some countries want to amend their contracts to reduce spending and to prevent receiving more […]


Manufacturing, Research and Development

Alnylam wins FDA approval of rare disease drug in step toward profitability

June 14, 2022

Via: Biopharma Dive

Alnylam, a pioneer in the drugmaking method known as RNA interference, has climbed the biotech industry ranks over the last two decades. After solving challenges associated with delivering these treatments into the body, Alnylam has become one of the sector’s […]


Clinical Trials, Research and Development

FDA’s treatment of China-developed drugs spurs demands for multiregional clinical trials

June 14, 2022

Via: Pharmaphorum

China’s emergence as an R&D powerhouse means that the country is quickly adding a number of drug candidates to the global pipeline. Despite more treatment options being a positive, Ben Hargreaves finds that this has raised issues over single-region clinical […]


Manufacturing, Research and Development

Resilience, a well-funded manufacturing startup, joins with the Parker Institute to make cancer drugs

June 9, 2022

Via: Biopharma Dive

While recent years have seen scientists make major advances in cutting-edge treatments such as gene and cell therapies, manufacturing remains a significant hurdle. The complex, multi-step processes required are beyond the capabilities of a traditional pharmaceutical plant. That’s where Resilience […]


Cell and Gene Therapy, Industry, Manufacturing, Research and Development

Regenxbio Opens Gene Therapy Manufacturing Facility

June 9, 2022

Via: Contract Pharma

Regenxbio recently celebrated the opening of its new Manufacturing Innovation Center gene therapy manufacturing facility. “Launching operations at our Manufacturing Innovation Center is an important milestone in the evolution of REGENXBIO,” said Kenneth T. Mills, president and CEO of REGENXBIO. […]


Manufacturing, Research and Development

Sana Biotechnology ditches California manufacturing plans in bid to save $100M

June 2, 2022

Via: FiercePharma

Sana Biotechnology, which raised a whopping $588 million in its initial public offering last year, has inked a deal for new manufacturing space. The preclinical-stage biotech is ditching plans to run its manufacturing operations in Fremont, California, and instead plans […]


Clinical Trials, Research and Development

FDA puts Sanofi’s Cialis prescription-to-OTC trial on hold, citing problems with study’s design

June 1, 2022

Via: FiercePharma

Sanofi’s effort to switch erectile dysfunction pill Cialis to over-the-counter (OTC) availability from its original prescription status has been slowed to a grinding halt with the FDA’s decision to put a trial on hold. The FDA halted an “actual use […]


Clinical Trials, Research and Development

Moleculin Commences Dosing in Healthy Volunteers in Phase 1a Clinical Trial of WP1122 for the Treatment of COVID-19

May 26, 2022

Via: Drugs.com

Moleculin Biotech, Inc., (“Moleculin” or the “Company”), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, today announced the commencement of dosing in its first-in-human Phase 1a study to evaluate the […]


Clinical Trials, Research and Development

FDA lifts hold on Ocugen’s COVID-19 vaccine trial. But is it too late for the shot?

May 23, 2022

Via: FiercePharma

Six weeks after slapping a clinical hold on a trial of Ocugen’s COVID-19 vaccine, the FDA has lifted it. That’s the good news for the Malvern, Pa. company, which has partnered with India’s Bharat Biotech on the shot known commercially […]


Clinical Trials, Research and Development

Death triggers FDA hold on Foghorn blood cancer clinical trial, shrouding timing of data drop

May 20, 2022

Via: FierceBiotech

The FDA has sounded a warning about Foghorn Therapeutics’ blood cancer candidate FHD-286, putting a phase 1 clinical trial on a partial hold in response to the death of a patient with potential differentiation syndrome. FHD-286 is an enzymatic inhibitor […]